Blue Calypso 10-Q/A 9 Oct 13 2013 Q1 Quarterly report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2013	13-May-13
Document and Entity Information [Abstract]
Entity Registrant Name	BLUE CALYPSO, INC.
Document Type	10-Q
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		132,838,336
Amendment Flag	TRUE
Amendment Description	This Amendment is being filed mainly to include restated financial statements as described in Note 2, Restatement of Previously Issued Financial Statements of the Notes to the condensed consolidated financial statements.
Entity Central Index Key	1399587
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Mar-13
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1

CONSOLIDATED_BALANCE_SHEETS_UN

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (RESTATED) (USD $)	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$64,593	$218,798
Accounts receivable	0	43,868
Prepaid expenses	18,988	3,052
Total current assets	83,581	265,718
Property and equipment, net of accumulated depreciation of $8,417 and 7,153 in 2013 and 2012 respectively	15,364	16,628
Capitalized software development costs, net of accumulated amortization of $419,923 and $352,957 in 2013 and 2012, respectively	914,822	923,449
Total assets	1,013,767	1,205,795
Current liabilities:
Accounts payable	75,635	84,947
Accrued liabilities	440,095	186,508
Unearned revenue		10,000
Notes Payable Current		766,253
Warrant liability	2,638,876	10,854,204
Debt liability- derivative	120,841	109,802
Total current liabilities	3,275,447	12,011,714
Notes Payable Noncurrent	905,484	236,500
Commitments and contingencies (note 10)
Total liabilities	4,180,931	12,248,214
Stockholders' equity (deficit)
Series A convertible preferred stock, par value $.0001 per share (Authorized 5,000,000 shares; issued and outstanding 1,700,000 shares)	170	170
Common stock, par value $.0001 per share (Authorized 680,000,000 shares; issued and outstanding shares of 125,135,113 as of 3/31/13 and 125,135,113 shares at 12/31/12 respectively)	12,514	12,514
Additional paid in capital	10,568,951	9,533,095
Deferred compensation	-2,938,713	-2,980,218
Accumulated deficit during development stage	-10,810,086	-17,607,980
Total stockholders' equity (deficit)	-3,167,164	-11,042,419
Total liabilities and stockholders' equity (deficit)	1,013,767	1,205,795
LMD [Member]
Current liabilities:
Notes Payable Current		465,000
Notes Payable Noncurrent	515,000
Affiliate [Member]
Current liabilities:
Notes Payable Current		301,253
Debenture [Member]
Current liabilities:
Notes Payable Noncurrent	$390,484	$236,500

CONSOLIDATED_BALANCE_SHEETS_UN1

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (RESTATED) (Parentheticals) (USD $)	Mar. 31, 2013	Dec. 31, 2012
Property and equipment, accumulated depreciation (in Dollars)	$8,417	$7,153
Capitalized software development costs, accumulated amortization (in Dollars)	419,923	352,957
Notes payable-affiliate, discount (in Dollars)	200,535
Series A Convertible Preferred stock, par value (in Dollars per share)	$0.00	$0.00
Series A Convertible Preferred stock, Authorized shares	5,000,000	5,000,000
Series A Convertible Preferred stock, issued shares	1,700,000	1,700,000
Series A Convertible Preferred stock, outstanding shares	1,700,000	1,700,000
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, Authorized shares	680,000,000	680,000,000
Common stock, issued shares	125,135,113	125,135,113
Common stock, outstanding shares	125,135,113	125,135,113
Affiliate [Member]
Notes payable-affiliate, discount (in Dollars)		244,705
Debenture [Member]
Note payable - debentures, discount (in Dollars)	$200,535	$213,500

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (RESTATED) (USD $)	3 Months Ended		43 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
REVENUE	$10,000	$584	$136,211
COST OF REVENUE	4,323	92,707	270,856
GROSS LOSS	5,677	-92,123	-134,645
OPERATING EXPENSES
Sales and marketing	125,957	243,425	1,414,311
General and administrative	923,151	962,626	6,819,387
Depreciation and Amortization	333,585	55,341	1,266,764
TOTAL OPERATING EXPENSES	1,382,693	1,261,392	9,500,462
LOSS FROM OPERATIONS	-1,377,016	-1,353,515	-9,635,107
OTHER INCOME (EXPENSE)
Interest income			15
Interest expense	-41,308	-5,700	-774,561
Change in fair value of derivative liabilities	8,216,218	-426,580	-400,433
TOTAL OTHER INCOME (EXPENSE)	8,174,910	-432,280	-1,174,979
INCOME OR (LOSS) BEFORE INCOME TAX PROVISION	6,797,894	-1,785,795	-10,810,086
INCOME TAX PROVISION
NET INCOME OR (LOSS)	$6,797,894	($1,785,795)	($10,810,086)
Income or Loss per share:
Basic (in Dollars per share)	$0.05	($0.01)
Weighted Average Shares Outstanding
Basic (in Shares)	130,893,388	127,003,882
Income or Loss per share:
Diluted (in Dollars per share)	$0.03	($0.01)
Weighted Average Shares Outstanding
Diluted (in Shares)	205,355,014	127,003,882

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)	November 2012 [Member]	November 2012 [Member]	December 2012 [Member]	December 2012 [Member]	December 2012 [Member]	Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Deferred Compensation, Share-based Payments [Member]	Accumulated Deficit during Development Stage [Member]	Total
	Additional Paid-in Capital [Member]	USD ($)	Additional Paid-in Capital [Member]	Accumulated Deficit during Development Stage [Member]	USD ($)	USD ($)	AP Settlements [Member]	Private Offering [Member]	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
	USD ($)		USD ($)	USD ($)
Beginning Balance, September 11, 2009 at Sep. 11, 2009
Net Loss												($23,653)	($23,653)
Ending Balance, at Dec. 31, 2009												-23,653	-23,653
Ending Balance, (in Shares) at Dec. 31, 2009
Shares issued at $.0001 per share-3/10/2010									6,545	-5,525			1,020
Shares issued at $.0001 per share-3/10/2010 (in Shares)									65,448,269
Conversion of Note Payable - Affiliate to Equity										21,958			21,958
Net Loss												-5,296	-5,296
Ending Balance, at Mar. 31, 2010									6,545	16,433		-28,949	-5,971
Ending Balance, (in Shares) at Mar. 31, 2010									65,448,269
Restricted shares issued									513	-433	-80
Restricted shares issued (in Shares)									5,133,198
Net Loss												-82,668	-82,668
Ending Balance, at Jun. 30, 2010									7,058	16,000	-80	-111,617	-88,639
Ending Balance, (in Shares) at Jun. 30, 2010									70,581,467
Restricted shares issued									160	-135	-25
Restricted shares issued (in Shares)									1,604,124
Net Loss												-115,880	-115,880
Ending Balance, at Sep. 30, 2010									7,219	15,864	-105	-227,497	-204,519
Ending Balance, (in Shares) at Sep. 30, 2010									72,185,591
Restricted shares vested											22		22
Net Loss												-185,191	-185,191
Ending Balance, at Dec. 31, 2010									7,219	15,864	-83	-412,688	-389,688
Beginning Balance, September 11, 2009 (in Shares) at Dec. 31, 2010									72,185,591
Restricted shares issued									128	-108	-20
Restricted shares issued (in Shares)									1,283,299
Additional paid-In capital-compensation cxpense										10			10
Restricted shares vested											12		12
Net Loss												-174,767	-174,767
Ending Balance, at Mar. 31, 2011									7,347	15,766	-91	-587,455	-564,433
Ending Balance, (in Shares) at Mar. 31, 2011									73,468,891
Restricted shares issued									128	-108	-20
Restricted shares issued (in Shares)									1,283,299
Restricted shares vested											15		15
Net Loss												-235,432	-235,432
Ending Balance, at Jun. 30, 2011									7,475	15,658	-96	-822,887	-799,850
Ending Balance, (in Shares) at Jun. 30, 2011									74,752,190
Restricted shares issued									32	21,752	-21,784		0
Restricted shares issued (in Shares)									320,825
Restricted shares cancelled									-288	192	96
Restricted shares cancelled (in Shares)									-2,887,423
Conversion of Debt									2,814	1,562,274			1,565,088
Conversion of Debt (in Shares)									28,135,234
Reverse merger shares issued 9/1/11									2,497	-2,497
Reverse merger shares issued 9/1/11 (in Shares)									24,974,700
Net Loss												-621,271	-621,271
Ending Balance, at Sep. 30, 2011									12,530	1,597,379	-21,784	-1,444,158	143,967
Ending Balance, (in Shares) at Sep. 30, 2011									125,295,526
Restricted shares issued										1,565,461	-1,565,616
Restricted shares issued (in Shares)									1,550,115
Allocation of proceeds from warrants										-712,828			-712,828
Additional paid-In capital-compensation cxpense										4,239			4,239
Restricted shares vested											5,446		5,446
Conversion of Debt						150				1,499,850			1,500,000
Conversion of Debt (in Shares)						1,500,000
Net Loss												-11,088,163	-11,088,163
Ending Balance, at Dec. 31, 2011						150			12,685	3,954,101	-1,581,954	-12,532,321	-10,147,339
Ending Balance, (in Shares) at Dec. 31, 2011						1,500,000			126,845,641
Restricted shares issued (in Shares)									200,000
Allocation of proceeds from warrants										-946,049			-946,049
Purchase of common stock - via AP settlements
Net Loss												-1,785,795	-1,785,795
Purchase of preferred stock										200,000			200,000
Purchase of preferred stock (in Shares)						200,000
Stock options - deferred income											763,480		763,480
Ending Balance, at Mar. 31, 2012						150			12,685	3,208,052	-818,474	-14,318,115	-11,915,702
Ending Balance, (in Shares) at Mar. 31, 2012						1,700,000			127,045,641
Restricted shares issued										5,234,337	-5,234,337
Restricted shares cancelled									-155	-1,565,461	1,565,616
Restricted shares cancelled (in Shares)									-1,700,115
Restricted shares - unvested									-24	-16,314	16,338
Restricted shares - unvested (in Shares)									-290,619
Purchase of common stock - related to private offering									44	186,479			186,523
Purchase of common stock - related to private offering (in Shares)									440,000
Release of common stock from shareholder (in Shares)									-440,000
Net Loss												-979,769	-979,769
Stock options - deferred income											2,181,627		2,181,627
Recording of restricted stock										145,398			145,398
Ending Balance, at Jun. 30, 2012						150			12,550	7,192,491	-2,289,230	-15,297,884	-10,381,923
Ending Balance, (in Shares) at Jun. 30, 2012						1,700,000			125,054,907
Restricted shares - unvested (in Shares)									80,205
Purchase of common stock - related to private offering									62	232,438			232,500
Purchase of common stock - related to private offering (in Shares)									450,000
Release of common stock from shareholder (in Shares)									-450,000
Net Loss												-856,619	-856,619
Stock options - deferred income											13,872		13,872
July 2012 warrant adjustment										-29,349			-29,349
Recording of restricted stock										436,194			436,194
Ending Balance, at Sep. 30, 2012						150			12,612	7,831,774	-2,275,358	-16,154,503	-10,585,325
Ending Balance, (in Shares) at Sep. 30, 2012						1,700,000			125,135,112
Purchase of common stock - related to private offering									-17	-29,983			-30,000
Purchase of common stock - related to private offering (in Shares)									10,000
Purchase of common stock - via AP settlements									107	354,788			354,895
Purchase of common stock - via AP settlements Shares (in Shares)									1,068,105
Release of common stock from shareholder (in Shares)							-1,068,105	-10,000
Correction to reflect preferred stock amount						20				-20
Restricted shares vested											5,446		5,446
Net Loss				-1,453,477	-1,453,477
Stock options - deferred income											-753,254		-753,254
Cumulative correction - common stock									-188	-42,760	42,948
Cumulative correction - common stock (in Shares)									1
Beneficial conversion feature - notes payable										614,696			614,696
Value of warrants -note payable										416,528			416,528
Recording of restricted stock										436,193			436,193
Warrants	-21,755	-21,755	-26,367		-26,367
Ending Balance, at Dec. 31, 2012						170			12,514	9,533,095	-2,980,218	-17,607,980	-11,042,419
Ending Balance, (in Shares) at Dec. 31, 2012						1,700,000			125,135,113
Conversion of Note Payable - Affiliate to Equity										552,995	41,505		594,500
Purchase of common stock - via AP settlements										30,000			30,000
Net Loss												6,797,894	6,797,894
Beneficial conversion feature - notes payable										16,667			16,667
Recording of restricted stock										436,194			436,194
Ending Balance, at Mar. 31, 2013						$170			$12,514	$10,568,951	($2,938,713)	($10,810,086)	($3,167,164)
Ending Balance, (in Shares) at Mar. 31, 2013						1,700,000			125,135,113

CONSOLIDATED_STATEMENTS_OF_CHA1

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) (USD $)	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2010
Shares issued, per share	$0.00	$0.00	$0.00

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (RESTATED) (USD $)	3 Months Ended		43 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (loss)	$6,797,894	($1,785,795)	($10,810,086)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	68,229	55,341	995,941
Amortization of vested restricted stock and options and Deferred compensation	743,055	763,481	3,977,479
Change in fair value of derivative liability	-8,216,218	426,580	400,433
Amortization of deferred debt discount	11,930		622,937
(Increase) decrease in assets:
Accounts receivable	43,868	32,200	0
Prepaid expenses and other current assets	-15,936	-2,841	-18,988
Increase (decrease) in liabilities:
Accounts payable	-9,312	46,003	75,635
Accounts payable-affiliate		-196,695	21,958
Accrued expenses	253,587	-58,947	443,682
Deferred revenue	-10,000	-3,284
Cash used in operating activities	-332,903	-723,957	-4,291,009
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for software development	-58,338	-176,973	-1,232,763
Cash paid for purchases of fixed assets			-23,781
Cash used in investing activities	-58,338	-176,973	-1,256,544
CASH FLOWS FROM FINANCING ACTIVITIES
Contributed capital received		-155	1,170
Increase in notes payable	207,036	350,693	1,667,995
Purchase of common stock			388,873
Purchase of preferred stock			200,000
Conversion of Notes Payable to equity		200,155	200,000
Conversion of AP to equity	30,000		3,154,108
Cash provided by financing activities	237,036	550,693	5,612,146
Net increase in cash	-154,205	-350,237	64,593
Cash at beginning of year	218,798	371,392
Cash at end of year	64,593	21,155	64,593
SUPPLEMENTAL INFORMATION:
Cash paid for interest	0		0
Cash paid for taxes
Non-cash investing and financing activities:
Conversion of notes payable and accounts payable -former affiliate to common stock	0		421,958
Former affiliate payable converted to note payable			545,958
Conversion of notes payable to common and preferred stock	0		2,769,214
Fair value of warrants issued in connection with preferred, common stock and notes payable		1,470,037	15,889,449
Fair value of conversion option issued in connection with notes payable			787,192
Fair value of warrants issued in settlement of accounts payable			$45,206

Organization_and_Nature_of_Bus

Organization and Nature of Business	3 Months Ended
	Mar. 31, 2013
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1.      Organization and Nature of Business
	Blue Calypso Holdings, Inc. (a development stage company) a Texas corporation (“BCHI”), was formed in February 2010 as an investment entity to hold a 100% single-member ownership interest in Blue Calypso, LLC, a Texas Limited Liability Company formed on September 11, 2009.  The companies are under common control and in February 2010 were merged for strategic operating purposes.
	On September 1, 2011, BCHI executed a share exchange agreement and merged with a public shell company Blue Calypso Acquisition, Corp., a wholly-owned subsidiary of Blue Calypso, Inc. (formerly known as “JJ&R Ventures, Inc.”).  The Merger was accounted for as a reverse-merger and recapitalization in accordance with the generally accepted accounting principles in the United States.  BCHI is the acquirer for financial reporting purposes and Blue Calypso, Inc. is the acquired company.  Consequently, the assets and liabilities and the operations that will be reflected in the historical financial statements prior to the Merger will be those of BCHI and will be recorded at its historical cost basis. The operations after completion of the Merger include those of BCHI and Blue Calypso Inc.  Common stock and corresponding capital amounts of BCHI pre-merger have been retroactively restated as capital stock shares reflecting the exchange ratio in the Merger.  On December 16, 2011 Blue Calypso Holdings, Inc. was merged into its 100% sole-owner, Blue Calypso, Inc.
	The Company is a mobile and social media marketing company that activates and measures branded word of mouth campaigns through consumers’ personal texts, posts and tweets between friends. The Company activates a friend to friend distribution of branded marketing campaigns by motivating brand loyalists to personally endorse and share these campaigns with their digital social streams. The Company compensates them for their reach with cash, prizes and VIP perks. Marketers enjoy the power of measured personal endorsements that generate buzz, ignite conversation, drive purchase intent, increase loyalty and attract new customers by leveraging the power of social influence.

Restatement_of_Previously_Issu

Restatement of Previously Issued Financial Statements	3 Months Ended
	Mar. 31, 2013
Restatement Of Previously Issued Financial Statement [Abstract]
Restatement Of Previously Issued Financial Statement [Text Block]	2.  Restatement of Previously Issued Financial Statements
	On August 26, 2013, after consulting with the Company’s Audit Committee, management changed its accounting for certain of the Company’s warrants previously issued in connection with preferred stock and common stock and conversion features related to previously issued convertible notes which were recorded in periods prior to the engagement of Marcum LLP in order to comply with US GAAP. Such warrants and the embedded conversion options should have been reflected as liabilities on the consolidated balance sheets included in the Original 10-Q, rather than as a component of equity.
	Specifically, the change in treatment of the warrants and the conversion feature embedded in certain convertible notes resulted in a change to the equity and liability portions of the consolidated balance sheets as of March 31, 2013 and resulted in a loss on the fair value of the derivative liabilities which impacted our results of operations and earnings (loss) per share as reported in our Original 10-Q.
	The effects of the revision on the accompanying balance sheet as of December 31, 2012 and March 31, 2013 is summarized below:
	Condensed Consolidated Balance Sheet
	31-Dec-12
		As previously reported	Adjustment	Reference	As Restated
	Assets	$1,205,795	$             -		$ 1,205,795
	Current liabilities:
	Conversion option liability	-	109,802	(a)	109,802
	Warrant liabilities	-	10,854,204	(a)	10,854,204
	Other current liabilities	1,047,708	0		1,047,708
	Total current liabilities	1,047,708	10,964,006		12,011,714
	Long term debt:	236,500	0		236,500
	Total liabilities	1,284,208	10,964,006		12,248,214
	Stockholders' deficiency
	Series A convertible preferred stock	170	-		170
	Common stock	12,514	-		12,514
	Additional paid in capital	10,251,657	(718,562)	(a)	9,533,095
	Additional paid in capital - deferred compensation	(2,980,218)	-	(a)	(2,980,218)
	Deficit accumulated during the development stage	(7,362,536)	(10,245,444)	(a)	(17,607,980)
	Total stockholders’ deficiency	(78,413)	(10,964,006)		(11,042,419)
	Total liabilities and stockholders' deficiency	$1,205,795	$             -		$ 1,205,795
	(a)     Reclassify cumulative effect of reclassifying warrants and conversion options with reset provisions as a liability and adjustment for accretion of stock based compensation.
	Condensed Consolidated Balance Sheet
	31-Mar-13
		As previously reported	Adjustment	Reference	As Restated
	Assets	$1,013,767	$           -		$ 1,013,767
	Current liabilities:
	Conversion option liability	-	120,841	(a)	120,841
	Warrant liabilities	-	2,638,876	(a)	2,638,876
	Other current liabilities	515,730	0		515,730
	Total current liabilities	515,730	2,759,717		3,275,447
	Long term debt:	905,484	0		905,484
	Total liabilities	1,421,214	2,759,717		4,180,931
	Stockholders' deficiency
	Series A convertible preferred stock	170	-		170
	Common stock	12,514	-		12,514
	Additional paid in capital	10,851,318	(282,367)	(a)	10,568,951
	Additional paid in capital - deferred compensation	(2,938,713)	-	(a)	(2,938,713)
	Deficit accumulated during the development stage	(8,332,736)	(2,477,350)	(a)	(10,810,086)
	Total stockholders’ deficiency	(407,447)	(2,759,717)		(3,167,164)
	Total liabilities and stockholders' deficiency	$1,013,767	$           -		$1,013,767
	(a)     Reclassify cumulative effect of reclassifying warrants and conversion options with reset provisions as a liability and adjustment for accretion of stock based compensation.
	The effects of the above described adjustments resulted in a change in the net gain or loss for the three months ended March 31, 2012 and March 31, 2013  and the period for the  inception to date through March  31, 2013.
		Three	Three	Inception
		Months	Months	to
		Ended	Ended	Date
		31-Mar-12	31-Mar-13	31-Mar-13
	Net Loss  (as originally presented)	$   (1,359,215)	$  (970,200)	$  (8,332,736)
	Change in operating expenses	-	(436,194)	(1,453,980)
	Change in fair value of derivative liabilities	(426,580)	8,216,218	(400,433)
	Increase in interest expense related to derivative liabilities	-	(11,930)	(622,937)
	Net gain or loss (as restated)	$ (1,785,795)	$ 6,797,894	$(10,810,086)
	Net loss per share - basic and diluted (as restated)	$         (0.01)	$        0.05
	Net loss per share - diluted (as restated)	$         (0.01)	$       0.03
	Weighted average shares outstanding - basic	127,003,882	130,893,388
	Weighted average shares outstanding diluted	127,003,882	204,722,215

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2013
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	3.      Summary of Significant Accounting Policies
	Development Stage Company
	The Company is a development stage company as defined by ASC 915 Development Stage Entities and is still devoting substantial efforts on establishing the business. Its principal operations have commenced but there has been no significant revenue thus far. All losses accumulated since inception, have been considered as part of the Company’s development stage activities.
	Basis of Presentation
	The financial statements are stated in U.S. dollars and include the accounts of Blue Calypso, Inc. and BCHI which were merged effective December 16, 2011. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.
	Segments
	The Company operates in a single segment.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the realization of capitalized software and the realization of deferred tax assets. Actual results may differ from these estimates.
	Revenue Recognition
	The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 605 “Revenue Recognition”, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, delivery of the product has occurred or services have been rendered and  collectability is reasonably assured. Revenue includes fees received from customers for advertising and marketing services provided by the Company and is recognized as earned when brand loyalists personally endorse and share the advertising campaigns with others in their digital social stream.
	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash held in bank demand deposits.  The Company considers all highly liquid debt instruments with original maturities of three months or less to be cash equivalents.
	Property and Equipment and Long-Lived Assets
	Property and equipment consists of office equipment and is recorded at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which for office equipment is three to five years. Expenditures for major renewals and betterments that extend the useful lives of the property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
	Intangible Assets
	Software development costs are accounted for in accordance with FASB ASC 350-40, Intangibles – Goodwill and Other: Internal Use Software. According to ASC 350-40 capitalization of costs shall begin when both of the following occur: a) preliminary project stage is completed,  b) management, with the relevant authority, implicitly or explicitly authorizes and commits to funding a computer software project and it is probable that the project will be completed and the software will be used to perform the function intended. The costs capitalized include fees paid to third parties for services provided to develop the software during the application development stage, payroll and payroll-related costs such as costs of employee benefits for employees who are directly associated with and who devote time to the internal-use computer software project on activities that include coding and testing during the application development stage and interest costs incurred while developing internal-use computer software (in accordance with ASC 835-20).  Once the software is ready for its intended use, the costs are amortized using straight-line method over the estimated useful life of up to five years. The unamortized capitalized cost of the software is compared annually to the net realizable value. The amount by which the unamortized capitalized costs of the internal use software exceed the net realizable value of that asset is written off.
	Impairment of Long-lived Tangible Assets and Definite-Lived Intangible Assets
	Long-lived tangible assets and definite lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable.  Recoverability of assets held and used is generally measured by a comparison of the carrying amount of an asset to undiscounted future net cash flows expected to be generated by that asset.  If it is determined that the carrying amount of an asset may not be recoverable, an impairment loss is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	Income Taxes
	Income taxes are accounted for using the asset and liability method pursuant to the authoritative guidance on Accounting for Income Taxes.  Deferred taxes are recognized for the tax consequences of "temporary differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement and carrying amounts and the tax bases of existing assets and liabilities.  The effect on deferred taxes for a change in tax rates is recognized in income in the period that includes the enactment date.  The Company recognizes future tax benefits to the extent that realization of such benefits is more likely than not.
	The Company follows the authoritative guidance prescribing comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that it has taken or expects to take on a tax return.  This guidance requires that a company recognize in its financial statements the impact of tax positions that meet a “more likely than not” threshold, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement.
	Loss per Share
	We have presented basic loss per share, computed on the basis of the weighted average number of common shares outstanding during the year, and diluted loss per share, computed on the basis of the weighted average number of common shares and all potentially dilutive common shares outstanding during the year. Potential common shares result from stock options, vesting of restricted stock grants and convertible notes. However, for the years presented, all outstanding stock options, restricted stock grants and convertible notes are anti-dilutive due to the losses incurred. Anti-dilutive common stock equivalents of 57,059,903 shares were excluded from the loss per share computation for three months ended March 31, 2012.
	Preferred Stock
	Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares, which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control, as temporary equity. At all other times, the Company classifies its preferred shares in stockholders’ deficiency. As of March 31, 2013, the Company does not have any preferred shares subject to mandatory redemption outstanding.
	Convertible Instruments
	GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.
	When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
	Common Stock Warrants and Other Derivative Financial Instruments
	The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	The Company’s free standing derivatives consist of warrants to purchase common stock that were issued in connection with its private placement transactions (see Note 7) and embedded conversion options with convertible notes. The Company evaluated these derivatives to assess their proper classification in the condensed consolidated balance sheets as of March 31, 2012 and December 31, 2012 using the applicable classification criteria enumerated under GAAP. The Company determined that certain common stock purchase warrants and the embedded conversion features do not contain fixed settlement provisions.  The exercise price of such warrants is subject to adjustment in the event that the Company subsequently issues equity securities or equity linked securities with exercise prices lower than the exercise price in these warrants. The convertible notes contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands.
	As such, the Company was required to record the warrants and debt derivative which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period.
	The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.
	Stock-Based Compensation
	The Company granted stock options and restricted stock as compensation to employees and directors.  Compensation expense is measured in accordance with FASB ASC 718 (formerly SFAS No. 123R), Compensation - Stock Compensation.  Compensation expense is recognized over the requisite service period for awards of equity instruments to employees based on the grant date fair value of those awards expected to ultimately vest.  Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.
	Concentrations of Credit Risk
	Significant concentrations of credit risk may arise from the Company’s cash maintained in the bank.  The Company maintains cash in quality financial institution, however, at times, cash balance may exceed the federal deposit insurance limits (FDIC limits).  As of March 31, 2013 and 2012, the cash balance with the bank did not exceed the $250,000 FDIC limit.
	Advertising and Marketing
	The Company's advertising and marketing costs, which consist primarily of marketing and trade show costs, business development and printed promotional and sales presentation materials, are charged to expense when incurred.  The advertising and marketing expense was $19,470 and $4,535 for the three months ended March 31, 2013 and 2012, respectively.
	Recent Accounting Pronouncements
	In July 2011, the Financial Accounting Standards Board (FASB) issued ASU 2012-06-Other Expenses (Topic 720): Fees Paid to the Federal Government by Health Insurers (a consensus of the FASB Emerging Issues Task Force). This ASU is effective for periods ending after December 31, 2013.  We do not expect this ASU 2012-06 to apply to the Company or to have a material effect on the financial position, results of operations or cash flows.
	In December 2011, the Financial Accounting Standards Board (FASB) issued ASU 2012-10-Property, Plant, and Equipment (Topic 360): De-recognition of in Substance Real Estate—a Scope Clarification (a consensus of the FASB Emerging Issues Task Force). This ASU is effective for periods after June 15, 2012.  We do not expect this ASU 2012-10 to apply to the Company or to have a material effect on the financial position, results of operations or cash flows.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2013
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	4.   Fair Value of Financial Instruments
	The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	ASC 820 describes three levels of inputs that may be used to measure fair value:
	Level 1 — quoted prices in active markets for identical assets or liabilities
	Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 — inputs that are unobservable based on an entity’s own assumptions, as there is little, if any, related market activity. (for example, cash flow modeling inputs based on assumptions)
	Financial liabilities as of March 31, 2013 and December 31, 2012 measured at fair value on a recurring basis are summarized below:
		March 31,		Quoted Prices		Significant		Significant
		2013		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities (as restated - see note 2)	$	2,759,717	$	--	$	--	$	2,759,717
		December 31,		Quoted Prices		Significant		Significant
		2012		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities (as restated - see note 2)	$	10,964,005	$	--	$	--	$	10,964,005
	The Company determined that the warrants issued in connection with certain financing transactions and certain conversion options related to convertible notes did not have fixed settlement provisions and are deemed to be derivative financial instruments, since the exercise prices were subject to adjustment based on certain subsequent equity issuances. Accordingly, the Company was required to record the warrants and conversion option as liabilities and mark all such derivatives to fair value each reporting period. Such instruments were classified within Level 3 of the valuation hierarchy.
	The fair value of the warrants and the conversion options was calculated using a binomial lattice formula with the following weighted average assumptions during the three ended March 31, 2013:
	Dividend Yield	0.00%
	Volatility	85.43% - 85.99%
	Risk-free Interest Rate	.11% - .77%
	Term	1.7 – 4.0 years
	The risk-free interest rate is the United States Treasury rate on the measurement date having a term equal to the remaining contractual life of the warrant. The volatility is a measure of the amount by which the Company’s share price has fluctuated or is expected to fluctuate. Since the Company’s common stock has not been publicly traded for a long period of time, an average of the historical volatility of comparative companies was used. The dividend yield is 0% as the Company has not made any dividend payment and has no plans to pay dividends in the foreseeable future.
	Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the warrant liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Chief Financial Officer, who reports to the Chief Executive Officer, determine its valuation policies and procedures.
	The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Chief Financial Officer and are approved by the Chief Executive Officer.
	Level 3 financial liabilities consist of the warrant liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.
	Significant observable and unobservable inputs include stock price, exercise price, annual risk free rate, term, and expected volatility, and are classified within Level 3 of the valuation hierarchy. An increase or decrease in volatility or interest free rate, in isolation, can significantly increase or decrease the fair value of the warrant. Changes in the values of the derivative liabilities are recorded as a component of other income (expense) on the Company’s condensed consolidated statements of operations.
	The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis for the three months ended March 31, 2013:
	Balance - Beginning of period (as restated - see note 2)	$	10,964,005
	Aggregate fair value of derivative instruments issued		11,930
	Change in fair value of derivative liabilities		-8,216,218
	Balance - End of period	$	2,759,717

Property_and_Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2013
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	5.  Property and Equipment
	Property and equipment consist of the following at March 31, 2013 and December 31, 2012:
		3/31/13		12/31/12
	Office Equipment	$	23,781	$	23,781
	Less: Accumulated depreciation		-8,417		-7,153
	Net property and equipment	$	15,364	$	16,628
	Depreciation expense was $1,264 and $1,189 for the three months ended March 31, 2013 and 2012, respectively.

Intangibles

Intangibles	3 Months Ended
	Mar. 31, 2013
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	6.  Intangibles
	Intangible assets consist of the following at March 31, 2013 and December 31, 2012:
		3/31/13		12/31/12
	Capitalized Software Development Costs	$	1,334,745	$	1,276,406
	Less: Accumulated amortization		-419,923		-352,957
	Net capitalized development costs	$	914,822	$	923,449
	The capitalized software development costs include $-0- interest capitalized for the three months ended March 31, 2013 and 2012, respectively.  The amortization expense relating to the capitalized development costs was $66,965 and $54,152 for the three months ended March 31, 2013 and 2012, respectively.  Amortization for the next five years is estimated to be as follows:
	2013	$	264,952
	2014		262,063
	2015		221,762
	2016		126,813
	2017		36,862
	Thereafter		2,370
	Total	$	914,822

Income_Tax_Provision

Income Tax Provision	3 Months Ended
	Mar. 31, 2013
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]
	7.  Income Tax Provision
	The company’s income taxes are recorded in accordance with ASC 740 “Income Taxes”. The tax effects of the Company’s temporary differences that give rise to significant portions of the deferred tax assets as of March 31, 2013 and 2012 consisted of net operating losses from inception to March 31, 2013 and 2012 of $10,810,086 and $14,318,115, respectively, which were fully reserved. Deferred tax assets and liabilities are computed by applying the effective U.S. federal and state income tax rate to the gross amounts of temporary differences and other tax attributes.
	In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. At March 31, 2013 and 2012, the Company believed it was more likely than not that future tax benefits from net operating loss carry-forwards and other deferred tax assets would not be realizable through generation of future taxable income and accordingly deferred tax assets are fully reserved.

Long_Term_Debt_Notes_Payable

Long Term Debt - Notes Payable	3 Months Ended
	Mar. 31, 2013
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	8.  Long Term Debt - Notes Payable
	On November 9, 2012, the Company entered into the exchange agreement with Aztec, pursuant to which the Company and Aztec agreed to exchange the Note and the Company's  existing accounts payable to Aztec for an 8% Convertible Note in the original principal amount of $545,958. The 8% Convertible Note is due on March 31, 2013. Pursuant to the exchange agreement, the Company agreed to register the shares of Common Stock issuable upon conversion of the 8% Convertible Note and an aggregate of 3,733,428 shares of Common Stock currently held by Aztec on or before December 31, 2012. The 8% Convertible Note is convertible into shares of the Company's Common Stock at a conversion price equal to the greater of: (i) $0.15 per share or (ii) the price per share at which Common Stock is sold in a subsequent financing. Upon effectiveness of the registration statement covering the resale of such shares, the 8% Convertible Note automatically convert into shares of the Company's Common Stock at the applicable conversion price.  Per the above agreement, the note converted to equity on February 12, 2013.
	The note was determined to have an embedded beneficial conversion feature (“BCF”) under the provisions of FAS ASC 470-20, “Debt with Conversion and Other Options” based on the issue date market value of $0.40 per share and the exercise price of $0.15 per share.  In accordance with ASC 470-20, an embedded beneficial conversion feature shall be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid capital.  A discount of $341,224 was recorded at issuance and amortization expense of $96,519 was recognized for the year ended December 31, 2012.   The note balance was $301,253 net of discount of $244,705 at December 31, 2012.  Amortization of the balance of the discount, $244,205 was recognized for the three months ended March 31, 2013.
	On April 19, 2012, the Company entered into a securities purchase agreement with an existing stockholder (the “Buyer”), pursuant to which the Company issued (i) a senior secured 8% convertible debenture convertible into shares of the Company at $0.10 per share in the original aggregate principal amount of $35,000 and (ii) a warrant to purchase 6,500,000 shares of common stock at $0.10 per share, and the Buyer covenanted to purchase up to an additional $465,000 of senior secured convertible debentures in a series of four closings at such times as may be designated by the Company in its sole discretion through November 30,  2012.  The convertible debentures matured on November 30, 2012 and bear interest at a rate of 8%.   A discount of $416,528 was recorded for the warrant fair market value and amortization expense was fully recognized in the amounts of $416,528 and $0 for the three months ended December 31, 2012, and 2011, respectively.  The unamortized discount balance was $0 as of December 31, 2012 and December 31, 2011, respectively.  The outstanding principal of the convertible debentures was $465,000 as of December 31, 2012.  The debentures were determined to have an embedded beneficial conversion feature (“BCF”) under the provisions of FAS ASC 470-20, “Debt with Conversion and Other Options” based on the issue date market value of $0.71 per share and the exercise price of $0.10 per share.
	In accordance with ASC 470-20, an embedded beneficial conversion feature shall be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid capital.  A discount of $48,472 was recorded at issuance and amortization expense of $48,472 was recognized for the year ended December 31, 2012.  An additional $50,000 was loaned as part of this agreement during the three months ended March 31, 2012.  The note balance was $515,000 net of discount of $0 at March 31, 2013.
	On November 15, 2012, the Company commenced a private offering of up to $3,000,000 of units at a purchase price of $50,000 per unit pursuant to the Securities Purchase Agreement dated November 15, 2012 (the “Purchase Agreement”). Each Unit consists of a 10% Convertible Debenture in the principal amount of $50,000 (the “Debenture”) and 12,500 shares of the Company’s common stock. The Debenture bears interest at a rate of 10% per annum, is due two years from the issuance date and is convertible into shares of the Company’s common stock at a conversion price of $0.20 per share. As of December 31, 2012, we have issued and sold an aggregate of 9 units totaling $450,000.  The debentures were determined to have an embedded beneficial conversion feature (“BCF”) under the provisions of FAS ASC 470-20, “Debt with Conversion and Other Options” based on the issue date market value of $0.40 per share and the exercise price of $0.20 per share.  In accordance with ASC 470-20, an embedded beneficial conversion feature shall be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional paid capital.  A discount of $225,000 was recorded at issuance and amortization expense of $11,500 was recognized for the year ended December 31, 2012.  For the quarter ended March 31, 2013 an additional $150,000 of debentures were issued and a discount of $16,667 was recorded.  Additionally, amortization of $29,632 was recorded.  The note balance was $399,465 net of discount of $200,535 at March 31, 2013.

Warrant_Derivative_Liabilities

Warrant Derivative Liabilities	3 Months Ended
	Mar. 31, 2013
Warrant Derivative Liability [Abstract]
Warrant Derivative Liability [Text Block]	9.   Warrant Derivative Liabilities
	The Company issued warrants in conjunction with the issuance of convertible debentures and the sale of Series A Convertible Preferred and Common Stock.  These warrants contain certain reset provisions. Therefore, in accordance with ASC 815-40, the Company classified the fair value of the warrant as a liability at the date of issuance.  Subsequent to the initial issuance date, the Company is required to adjust the warrant to fair value as an adjustment to current period operations.
	The Company recorded a gain (loss) on change in fair value of derivative liabilities of $8,216,218 and $(426,580) for the three months ended March 31, 2013 and 2012, respectively.

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)	3 Months Ended
	Mar. 31, 2013
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	10.  Stockholders’ Equity (Deficit)
	On June 13, 2012, the Company commenced a private placement of up to $10,000,000 of Units, at a purchase price of $1.00 per Unit. Each Unit consists of: (i) two shares of Common Stock and (ii) a warrant to purchase one share of the Company’s Common Stock (the “Warrant”). The Warrant is exercisable for a term of two years at an exercise price of $0.75 per share. As of October 14, 2012, the termination date of the offering, we issued and sold an aggregate of 445,000 Units in consideration of gross proceeds of $445,000. As a result, the Company issued an aggregate of 890,000 shares of common stock and warrants to purchase an aggregate of 890,000 shares of Common Stock.  WFG Investments, Inc. (“WFG”) acted as placement agent in connection with the Private Placement and received a commission equal to 10% of any subscriptions received and warrants to purchase 3% of the number of shares of common stock included in the Units sold in the Private Placement. As December 31, 2012, WFG received a cash fee of $44,500 and warrants to purchase 26,700 shares of common stock.
	In April 2012, the Company entered into a stockholder’s agreement with Andrew Levi, our Chief Technology Officer, whereby Mr. Levi agreed to place 25,000,000 shares of Common Stock held by him in escrow for a period of one year. In the event that the Company issues shares of Common Stock in a financing transaction or in connection with the hiring or retention of senior management or directors during such period of time, the corresponding number of escrowed shares will be cancelled and returned to the Company’s treasury.
	On September 1, 2011 and as part of the reverse merger, the Company issued convertible promissory notes (the “Promissory Notes”) to two accredited investors in a private placement transaction (the “Private Placement”) pursuant to a Securities Purchase Agreement (the “Securities Purchase Agreement”) in the aggregate principal amount of One Million Five Hundred Thousand Dollars ($1,500,000) and five-year warrants (the “Warrants”) to purchase up to 22,091,311 shares of the Company’s common stock at an exercise price of $0.10 per share. The notes are due December 1, 2012 and accrue no interest. The Promissory Notes are automatically convertible at $1 into One Million Five Hundred Thousand (1,500,000) shares of the Company’s Series A Convertible Preferred Stock (“Series A Preferred”) immediately upon the creation of the Series A Preferred by the Company. The Series A Preferred stock was approved October 17, 2011 and the notes were immediately converted into 1,500,000 preferred shares. The Series A Preferred shares are convertible into shares of the Company’s common stock at a conversion rate of $0.0679 per share or 22,091,311 common shares. The conversion of preferred into common stock is limited to the extent that the beneficial owners own greater that 4.99% of the Company’s common stock.
	During the three months ended March 31, 2012, the investor completed the purchase of the additional 200,000 shares of Series A Preferred and warrants to purchase an additional 2,945,509 shares of common stock.  The conversion of Series A Preferred into common stock and exercise of warrants is limited to the extent that the beneficial owners own greater that 4.99% of the Company’s common stock.
	Blue Calypso, Inc. is authorized to issue 685,000,000 shares of capital stock: 680,000,000 shares of common stock with voting rights at a par value of $.0001 and 5,000,000 shares of Series A Convertible Preferred Stock, also at $.0001 par value per share.  There were 125,135,112 shares of common stock issued and outstanding as of March 31, 2013.  There were 1,700,000 shares of preferred stock were issued and outstanding as of March 31, 2013.  The Company did not make or declare any distributions to shareholders during the quarters ended March 31, 2013 or March 31, 2012.
	Long-Term Incentive Plan
	The stockholders approved the Blue Calypso, Inc. 2011 Long-Term Incentive Plan (the “Plan”) on September 9, 2011.  The Plan provides for the granting of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights, and other awards which may be granted singly, in combination, or in tandem, and which may be paid in cash or shares of common stock.  Subject to certain adjustments, the maximum number of shares of common stock that may be delivered pursuant to awards under the Plan is 35,000,000 shares.
	Stock Options
	During the three months ended March 31, 2013, the Company granted options to purchase 5,218,530 shares of the Company’s common stock to employees, non-employee board members and other consultants under the Plan.
	During 2012 the Company granted options to purchase 9,873,543 shares of the Company’s common stock to employees, non-employee board members and other consultants under the Plan
	The options vest under a number of different vesting schedules.  The fair value for the Company’s options were estimated at the date of grant using the Black-Scholes option pricing model with the weighted average assumptions as noted in the following table.  The Black-Scholes option valuation model incorporate ranges of assumptions for inputs, and those ranges are disclosed below.  Expected volatilities are based on similar industry-sector indices.
	The expected life of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free interest rate assumption is based on market yield on U.S. Treasury securities at 5-year constant maturity,  quoted on investment basis determined at the date of grant.
	Assumptions used for employee stock options:
	Risk-free interest rate	0	.77 to .86%
	Dividend yield		0%
	Stock price volatility		20% - 37%
	Expected life		5.75 years
	Using the valuation assumptions noted above, the Company estimated the value of stock options granted to be $549,926 and $1,953,072  for the three months ended March 31, 2013 and 2012, respectively.  The 4,578,530 of the March 31, 2013 options were granted February 21, 2013 when the stock price was at $0.24 per share.  The value of these options is being amortized to stock-based compensation expense annually over their three year vesting period. The stock-based compensation expense recorded was $41,506 and $763,480 during the three months ended March 31, 2013 and 2012, respectively.      The following table summarizes the stock option activity as of March 31, 2013:
		Outstanding		Weighted
		Options		Average
				Exercise
				Price
	Balance, December 31, 2012	9,460,543		$	0.2498
	Granted	5,218,530			0.2383
	Exercised	0			0
	Cancelled	0			0
	Balance, March 31, 2013	14,679,073		$	0.2457
	Exercisable at 3/31/13	7,546,659		$	0.1982
	Non-vested at 3/31/13	7,132,414		$	0.296
	Restricted Stock
	The restricted stock granted prior to the reverse merger transaction, have been retroactively restated as capital stock shares reflecting the exchange ratio in the Merger.
	The following table summarizes the restricted stock activity for the three months ended March 31, 2013:
	Restricted Shares Activity:
		Restricted shares issued as of December 31, 2012		13,456,667
		Granted during three months ended March 31, 2013		0
		Forfeited during three months ended March 31, 2013		0
		Total Restricted Shares Issued at March 31, 2013		13,456,667
		Vested at March 31, 2013		-160,412
		Unvested restricted shares as of March 31, 2013		13,296,255
	A total of 13,285,842 shares were granted in 2012 and will vest 1/3 in the first year following the grant and the balance over the following 8 calendar quarters. The share based compensation expense was $436,194 and $0 for the three months ended March 31, 2013 and 2012, respectively. As of March 31, 2013, the unamortized stock based compensation related to restricted stock is $3,940,039 and will be amortized over the remaining period of approximately 2 years.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2013
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	11.  Related Party Transactions
	Aztec Systems, Inc. (“Aztec”) was an affiliate of the Company that provided administrative and technical support services to the Company.  The majority owner of Aztec was also the majority stockholder of the Company until the date of sale of Aztec on June 15, 2012.
	On November 9, 2012, the Company entered into an exchange agreement with Aztec, pursuant to which the Company and Aztec agreed to exchange its note payable to Aztec and the Company's  existing accounts payable to Aztec for an 8% Convertible Note in the original principal amount of $545,958. The 8% Convertible Note was due on March 31, 2013. Pursuant to the exchange agreement, the  Company agreed to register the shares of Common Stock issuable upon conversion of the 8% Convertible Note and an aggregate of 3,686,634 shares of Common Stock currently held by Aztec on or before December 31, 2012. The 8% Convertible Note was convertible into shares of the Company's Common Stock at a conversion price equal to the greater of: (i) $0.15 per share or (ii) the price per share at which Common Stock is sold in a subsequent financing. Upon effectiveness of the registration statement covering the resale of such shares, the 8% Convertible Note automatically converted into shares of the Company's Common Stock at the applicable conversion price. As per the above agreement, the 8% Convertible Note was converted to Common Stock on February 12, 2013 upon effectiveness of the Company's Registration Statement on Form S-1.

LiquidityGoing_Concern

Liquidity-Going Concern	3 Months Ended
	Mar. 31, 2013
Liquidity Going Concern Disclosure [Abstract]
Liquidity Going Concern Disclosure [Text Block]	12.  Liquidity-Going Concern
	These financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the Company will need additional financing to continue to operate and fully implement its business plan.    Management believes that the current cash and revenue should fund the Company’s expected burn rate into the second quarter of 2013.  The Company will require additional funds to continue operations.
	The Company completed a private placement on May 6, 2013 resulting in gross proceeds to the Company of $2,400,000; refer to the subsequent event Note 14.
	The Company has accumulated losses from September 11, 2009 (inception) through March 31, 2013 of $8,296,537.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2013
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	13.  Commitments and Contingencies
	The Company leases office space under a month to month operating lease with no minimum future rental payments.  The operating lease does not involve contingent liabilities. Rental expense under the operating lease totaled $9,978 and $0 for the three months ended March 31, 2013 and 2012, respectively.
	.
	From time to time, the Company is involved in various legal matters in the ordinary course of business. In the opinion of management the ultimate liability, if any resulting from such legal matters will not have a material effect on the Company’s financial position or results of operations.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2013
Subsequent Events [Abstract]
Subsequent Events [Text Block]	14.  Subsequent Events
	The Company evaluated events or transactions occurring after March 31, 2013, the balance sheet date, through May 15, 2013, and September 30, 2013 from footnote 2, the date the financial statements were available to be issued, and determined any events or transactions which could impact the financial statements as of and for the three months ended March 31, 2013.
	On May 6, 2013, the Company entered into a Securities Purchase Agreement with an accredited investor pursuant to which it issued and sold a 10% Convertible Debenture in the principal amount of $2,400,000 (the “Debenture”) and 1,200,000 shares of common stock in consideration of gross proceeds to the Company of $2,400,000. The Debenture bears interest at a rate of 10% per annum, is due two years from the issuance date and is convertible into shares of the Company’s common stock at a conversion price of $0.25 per share.
	On April 29, 2013, the Company entered into a series of agreements with the LMD, the holder of its 8% Senior Secured Convertible Debentures The Debentures were due on November 30, 2012. As of April 29, 2013, the aggregate amount outstanding under the Debentures, including all accrued and unpaid interest and fees, was $600,000. Pursuant to Amendment No. 1 to 8% Senior Secured Convertible Debentures, the conversion price of the Debentures was amended such that the aggregate amount outstanding under the Debentures will be convertible into an aggregate of 20,000,000 shares of the Company’s common stock. The issuance of the Conversion Shares will not result in any dilution to the existing stockholders of the Company as the Company’s Founder and Chief Technology Officer, Andrew Levi, has agreed to cancel and return to treasury 20,000,000 shares of common stock currently held by him in connection with this transaction. LMD also agreed to immediately terminate the Security Agreement dated April 19, 2012 by and between the Company, the Company’s subsidiaries and the LMD, the Intellectual Property Security Agreement dated April 19, 2012 by and between the Company, the Company’s subsidiaries and the LMD, and the Subsidiary Guarantee executed by the Company’s subsidiary, Blue Calypso, LLC, and all of the security interests created thereby. The maturity dates of the Debentures were extended to June 30, 2013.
	In connection with the Amendment to 8% Debentures, the Company and the LMD also agreed to amend the terms of certain warrants currently held by LMD. The Company agreed to extend the maturity date of the warrants originally issued to LMD in September 2011 to April 30, 2018 and to extend the anti-dilution protection of such warrants for the life of the warrants. Pursuant to Amendment to the Common Stock Purchase Warrant, the Company agreed to extend the maturity date of the warrants originally issued to the LMD in April 2012 to April 30, 2018 and to extend the anti-dilution protection of such warrants for the life of the warrants.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2013
Accounting Policies [Abstract]
Development Stage Company, Policy [Policy Text Block]	Development Stage Company
	The Company is a development stage company as defined by ASC 915 Development Stage Entities and is still devoting substantial efforts on establishing the business. Its principal operations have commenced but there has been no significant revenue thus far. All losses accumulated since inception, have been considered as part of the Company’s development stage activities.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation
	The financial statements are stated in U.S. dollars and include the accounts of Blue Calypso, Inc. and BCHI which were merged effective December 16, 2011. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.
Segment Reporting, Policy [Policy Text Block]	Segments
	The Company operates in a single segment.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the realization of capitalized software and the realization of deferred tax assets. Actual results may differ from these estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 605 “Revenue Recognition”, when persuasive evidence of an arrangement exists, the fee is fixed or determinable, delivery of the product has occurred or services have been rendered and  collectability is reasonably assured. Revenue includes fees received from customers for advertising and marketing services provided by the Company and is recognized as earned when brand loyalists personally endorse and share the advertising campaigns with others in their digital social stream.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash held in bank demand deposits.  The Company considers all highly liquid debt instruments with original maturities of three months or less to be cash equivalents.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment and Long-Lived Assets
	Property and equipment consists of office equipment and is recorded at cost, less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which for office equipment is three to five years. Expenditures for major renewals and betterments that extend the useful lives of the property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets
	Software development costs are accounted for in accordance with FASB ASC 350-40, Intangibles – Goodwill and Other: Internal Use Software. According to ASC 350-40 capitalization of costs shall begin when both of the following occur: a) preliminary project stage is completed,  b) management, with the relevant authority, implicitly or explicitly authorizes and commits to funding a computer software project and it is probable that the project will be completed and the software will be used to perform the function intended. The costs capitalized include fees paid to third parties for services provided to develop the software during the application development stage, payroll and payroll-related costs such as costs of employee benefits for employees who are directly associated with and who devote time to the internal-use computer software project on activities that include coding and testing during the application development stage and interest costs incurred while developing internal-use computer software (in accordance with ASC 835-20).  Once the software is ready for its intended use, the costs are amortized using straight-line method over the estimated useful life of up to five years. The unamortized capitalized cost of the software is compared annually to the net realizable value. The amount by which the unamortized capitalized costs of the internal use software exceed the net realizable value of that asset is written off.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-lived Tangible Assets and Definite-Lived Intangible Assets
	Long-lived tangible assets and definite lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable.  Recoverability of assets held and used is generally measured by a comparison of the carrying amount of an asset to undiscounted future net cash flows expected to be generated by that asset.  If it is determined that the carrying amount of an asset may not be recoverable, an impairment loss is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Income Tax, Policy [Policy Text Block]	Income Taxes
	Income taxes are accounted for using the asset and liability method pursuant to the authoritative guidance on Accounting for Income Taxes.  Deferred taxes are recognized for the tax consequences of "temporary differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement and carrying amounts and the tax bases of existing assets and liabilities.  The effect on deferred taxes for a change in tax rates is recognized in income in the period that includes the enactment date.  The Company recognizes future tax benefits to the extent that realization of such benefits is more likely than not.
	The Company follows the authoritative guidance prescribing comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that it has taken or expects to take on a tax return.  This guidance requires that a company recognize in its financial statements the impact of tax positions that meet a “more likely than not” threshold, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement.
Earnings Per Share, Policy [Policy Text Block]	Loss per Share
	We have presented basic loss per share, computed on the basis of the weighted average number of common shares outstanding during the year, and diluted loss per share, computed on the basis of the weighted average number of common shares and all potentially dilutive common shares outstanding during the year. Potential common shares result from stock options, vesting of restricted stock grants and convertible notes. However, for the years presented, all outstanding stock options, restricted stock grants and convertible notes are anti-dilutive due to the losses incurred. Anti-dilutive common stock equivalents of 57,059,903 shares were excluded from the loss per share computation for three months ended March 31, 2012.
Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]	Preferred Stock
	Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares, which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control, as temporary equity. At all other times, the Company classifies its preferred shares in stockholders’ deficiency. As of March 31, 2013, the Company does not have any preferred shares subject to mandatory redemption outstanding.
Convertible Instruments, Policy [Policy Text Block]	Convertible Instruments
	GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.
	When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company also records, when necessary, deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.
Common Stock Warrants And Other Derivative Financial Instrument, Policy [Policy Text Block]	Common Stock Warrants and Other Derivative Financial Instruments
	The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	The Company’s free standing derivatives consist of warrants to purchase common stock that were issued in connection with its private placement transactions (see Note 7) and embedded conversion options with convertible notes. The Company evaluated these derivatives to assess their proper classification in the condensed consolidated balance sheets as of March 31, 2012 and December 31, 2012 using the applicable classification criteria enumerated under GAAP. The Company determined that certain common stock purchase warrants and the embedded conversion features do not contain fixed settlement provisions.  The exercise price of such warrants is subject to adjustment in the event that the Company subsequently issues equity securities or equity linked securities with exercise prices lower than the exercise price in these warrants. The convertible notes contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands.
	As such, the Company was required to record the warrants and debt derivative which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period.
	The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus any available shares are allocated first to contracts with the most recent inception dates.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Based Compensation
	The Company granted stock options and restricted stock as compensation to employees and directors.  Compensation expense is measured in accordance with FASB ASC 718 (formerly SFAS No. 123R), Compensation - Stock Compensation.  Compensation expense is recognized over the requisite service period for awards of equity instruments to employees based on the grant date fair value of those awards expected to ultimately vest.  Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk
	Significant concentrations of credit risk may arise from the Company’s cash maintained in the bank.  The Company maintains cash in quality financial institution, however, at times, cash balance may exceed the federal deposit insurance limits (FDIC limits).  As of March 31, 2013 and 2012, the cash balance with the bank did not exceed the $250,000 FDIC limit.
Advertising Costs, Policy [Policy Text Block]	Advertising and Marketing
	The Company's advertising and marketing costs, which consist primarily of marketing and trade show costs, business development and printed promotional and sales presentation materials, are charged to expense when incurred.  The advertising and marketing expense was $19,470 and $4,535 for the three months ended March 31, 2013 and 2012, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements
	In July 2011, the Financial Accounting Standards Board (FASB) issued ASU 2012-06-Other Expenses (Topic 720): Fees Paid to the Federal Government by Health Insurers (a consensus of the FASB Emerging Issues Task Force). This ASU is effective for periods ending after December 31, 2013.  We do not expect this ASU 2012-06 to apply to the Company or to have a material effect on the financial position, results of operations or cash flows.
	In December 2011, the Financial Accounting Standards Board (FASB) issued ASU 2012-10-Property, Plant, and Equipment (Topic 360): De-recognition of in Substance Real Estate—a Scope Clarification (a consensus of the FASB Emerging Issues Task Force). This ASU is effective for periods after June 15, 2012.  We do not expect this ASU 2012-10 to apply to the Company or to have a material effect on the financial position, results of operations or cash flows

Restatement_of_Previously_Issu1

Restatement of Previously Issued Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2013
Adjustment of Balance Sheeet [Member]
Restatement of Previously Issued Financial Statements (Tables) [Line Items]
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]	Condensed Consolidated Balance Sheet
	31-Dec-12
		As previously reported	Adjustment	Reference	As Restated
	Assets	$1,205,795	$             -		$ 1,205,795
	Current liabilities:
	Conversion option liability	-	109,802	(a)	109,802
	Warrant liabilities	-	10,854,204	(a)	10,854,204
	Other current liabilities	1,047,708	0		1,047,708
	Total current liabilities	1,047,708	10,964,006		12,011,714
	Long term debt:	236,500	0		236,500
	Total liabilities	1,284,208	10,964,006		12,248,214
	Stockholders' deficiency
	Series A convertible preferred stock	170	-		170
	Common stock	12,514	-		12,514
	Additional paid in capital	10,251,657	(718,562)	(a)	9,533,095
	Additional paid in capital - deferred compensation	(2,980,218)	-	(a)	(2,980,218)
	Deficit accumulated during the development stage	(7,362,536)	(10,245,444)	(a)	(17,607,980)
	Total stockholders’ deficiency	(78,413)	(10,964,006)		(11,042,419)
	Total liabilities and stockholders' deficiency	$1,205,795	$             -		$ 1,205,795
	(a)     Reclassify cumulative effect of reclassifying warrants and conversion options with reset provisions as a liability and adjustment for accretion of stock based compensation.
	Condensed Consolidated Balance Sheet
	31-Mar-13
		As previously reported	Adjustment	Reference	As Restated
	Assets	$1,013,767	$           -		$ 1,013,767
	Current liabilities:
	Conversion option liability	-	120,841	(a)	120,841
	Warrant liabilities	-	2,638,876	(a)	2,638,876
	Other current liabilities	515,730	0		515,730
	Total current liabilities	515,730	2,759,717		3,275,447
	Long term debt:	905,484	0		905,484
	Total liabilities	1,421,214	2,759,717		4,180,931
	Stockholders' deficiency
	Series A convertible preferred stock	170	-		170
	Common stock	12,514	-		12,514
	Additional paid in capital	10,851,318	(282,367)	(a)	10,568,951
	Additional paid in capital - deferred compensation	(2,938,713)	-	(a)	(2,938,713)
	Deficit accumulated during the development stage	(8,332,736)	(2,477,350)	(a)	(10,810,086)
	Total stockholders’ deficiency	(407,447)	(2,759,717)		(3,167,164)
	Total liabilities and stockholders' deficiency	$1,013,767	$           -		$1,013,767
	(a)     Reclassify cumulative effect of reclassifying warrants and conversion options with reset provisions as a liability and adjustment for accretion of stock based compensation.
Adjustment of Income Statement [Member]
Restatement of Previously Issued Financial Statements (Tables) [Line Items]
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]		Three	Three	Inception
		Months	Months	to
		Ended	Ended	Date
		31-Mar-12	31-Mar-13	31-Mar-13
	Net Loss  (as originally presented)	$   (1,359,215)	$  (970,200)	$  (8,332,736)
	Change in operating expenses	-	(436,194)	(1,453,980)
	Change in fair value of derivative liabilities	(426,580)	8,216,218	(400,433)
	Increase in interest expense related to derivative liabilities	-	(11,930)	(622,937)
	Net gain or loss (as restated)	$ (1,785,795)	$ 6,797,894	$(10,810,086)
	Net loss per share - basic and diluted (as restated)	$         (0.01)	$        0.05
	Net loss per share - diluted (as restated)	$         (0.01)	$       0.03
	Weighted average shares outstanding - basic	127,003,882	130,893,388
	Weighted average shares outstanding diluted	127,003,882	204,722,215

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2013
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]		March 31,		Quoted Prices		Significant		Significant
		2013		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities (as restated - see note 2)	$	2,759,717	$	--	$	--	$	2,759,717
		December 31,		Quoted Prices		Significant		Significant
		2012		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Derivative liabilities (as restated - see note 2)	$	10,964,005	$	--	$	--	$	10,964,005
Schedule of Warrants and Conversion Options , Valuation Assumptions [Table Text Block]	Dividend Yield	0.00%
	Volatility	85.43% - 85.99%
	Risk-free Interest Rate	.11% - .77%
	Term	1.7 – 4.0 years
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
	Balance - Beginning of period (as restated - see note 2)	$	10,964,005
	Aggregate fair value of derivative instruments issued		11,930
	Change in fair value of derivative liabilities		-8,216,218
	Balance - End of period	$	2,759,717

Property_and_Equipment_Tables

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2013
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		3/31/13		12/31/12
	Office Equipment	$	23,781	$	23,781
	Less: Accumulated depreciation		-8,417		-7,153
	Net property and equipment	$	15,364	$	16,628

Intangibles_Tables

Intangibles (Tables)	3 Months Ended
	Mar. 31, 2013
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]		3/31/13		12/31/12
	Capitalized Software Development Costs	$	1,334,745	$	1,276,406
	Less: Accumulated amortization		-419,923		-352,957
	Net capitalized development costs	$	914,822	$	923,449
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2013	$	264,952
	2014		262,063
	2015		221,762
	2016		126,813
	2017		36,862
	Thereafter		2,370
	Total	$	914,822

Stockholders_Equity_Deficit_Ta

Stockholders' Equity (Deficit) (Tables)	3 Months Ended
	Mar. 31, 2013
Stockholders' Equity Note [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Assumptions used for employee stock options:
	Risk-free interest rate	0	.77 to .86%
	Dividend yield		0%
	Stock price volatility		20% - 37%
	Expected life		5.75 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]		Outstanding		Weighted
		Options		Average
				Exercise
				Price
	Balance, December 31, 2012	9,460,543		$	0.2498
	Granted	5,218,530			0.2383
	Exercised	0			0
	Cancelled	0			0
	Balance, March 31, 2013	14,679,073		$	0.2457
	Exercisable at 3/31/13	7,546,659		$	0.1982
	Non-vested at 3/31/13	7,132,414		$	0.296
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
	Restricted Shares Activity:
		Restricted shares issued as of December 31, 2012		13,456,667
		Granted during three months ended March 31, 2013		0
		Forfeited during three months ended March 31, 2013		0
		Total Restricted Shares Issued at March 31, 2013		13,456,667
		Vested at March 31, 2013		-160,412
		Unvested restricted shares as of March 31, 2013		13,296,255

Organization_and_Nature_of_Bus1

Organization and Nature of Business (Details)	Mar. 31, 2013
Disclosure Text Block [Abstract]
Noncontrolling Interest, Ownership Percentage by Parent	100.00%

Restatement_of_Previously_Issu2

Restatement of Previously Issued Financial Statements (Details) - The effects of revision balance sheet (USD $)	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 10, 2009
Assets	$1,013,767	$1,205,795
Current liabilities:
Conversion option liability	120,841	109,802
Warrant liabilities	2,638,876	10,854,204
Total current liabilities	3,275,447	12,011,714
Total liabilities	4,180,931	12,248,214
Stockholders' deficiency
Series A convertible preferred stock	170	170
Common stock	12,514	12,514
Additional paid in capital	10,568,951	9,533,095
Additional paid in capital - deferred compensation	2,938,713	2,980,218
Deficit accumulated during the development stage	10,810,086	17,607,980
Total stockholdersb deficiency	-3,167,164	-11,042,419	-10,585,325	-10,381,923	-11,915,702	-10,147,339	143,967	-799,850	-564,433	-389,688	-204,519	-88,639	-5,971	-23,653
Total liabilities and stockholders' deficiency	1,013,767	1,205,795
Scenario, Previously Reported [Member]
Assets	1,013,767	1,205,795
Current liabilities:
Conversion option liability
Warrant liabilities
Other current liabilities	515,730	1,047,708
Total current liabilities	515,730	1,047,708
Long term debt:	905,484	236,500
Total liabilities	1,421,214	1,284,208
Stockholders' deficiency
Series A convertible preferred stock	170	170
Common stock	12,514	12,514
Additional paid in capital	10,851,318	10,251,657
Additional paid in capital - deferred compensation	-2,938,713	-2,980,218
Deficit accumulated during the development stage	-8,332,736	-7,362,536
Total stockholdersb deficiency	-407,447	-78,413
Total liabilities and stockholders' deficiency	1,013,767	1,205,795
Scenario, Adjustment [Member]
Assets
Current liabilities:
Conversion option liability	120,841	109,802
Warrant liabilities	2,638,876	10,854,204
Other current liabilities	0	0
Total current liabilities	2,759,717	10,964,006
Long term debt:	0	0
Total liabilities	2,759,717	10,964,006
Stockholders' deficiency
Series A convertible preferred stock
Common stock
Additional paid in capital	-282,367	-718,562
Additional paid in capital - deferred compensation
Deficit accumulated during the development stage	-2,477,350	-10,245,444
Total stockholdersb deficiency	-2,759,717	-10,964,006
Total liabilities and stockholders' deficiency
Restatement Adjustment [Member]
Assets	1,013,767	1,205,795
Current liabilities:
Conversion option liability	120,841	109,802
Warrant liabilities	2,638,876	10,854,204
Other current liabilities	515,730	1,047,708
Total current liabilities	3,275,447	12,011,714
Long term debt:	905,484	236,500
Total liabilities	4,180,931	12,248,214
Stockholders' deficiency
Series A convertible preferred stock	170	170
Common stock	12,514	12,514
Additional paid in capital	10,568,951	9,533,095
Additional paid in capital - deferred compensation	-2,938,713	-2,980,218
Deficit accumulated during the development stage	-10,810,086	-17,607,980
Total stockholdersb deficiency	-3,167,164	-11,042,419
Total liabilities and stockholders' deficiency	$1,013,767	$1,205,795

Restatement_of_Previously_Issu3

Restatement of Previously Issued Financial Statements (Details) - Condensed Net Loss Adjustments (USD $)	3 Months Ended													43 Months Ended
	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Mar. 31, 2013
Net gain or loss	$6,797,894	($856,619)	($979,769)	($1,785,795)	($11,088,163)	($621,271)	($235,432)	($174,767)	($185,191)	($115,880)	($82,668)	($5,296)	($23,653)	($10,810,086)
Net loss per share - diluted (as restated) (in Dollars per share)	$0.03			($0.01)
Weighted average shares outstanding - basic (in Shares)	130,893,388			127,003,882
Weighted average shares outstanding diluted (in Shares)	205,355,014			127,003,882
Change in operating expenses	1,382,693			1,261,392										9,500,462
Change in fair value of derivative liabilities	8,216,218			-426,580										-400,433
Scenario, Previously Reported [Member]
Net gain or loss	-970,200			-1,359,215										-8,332,736
Scenario, Adjustment [Member]
Change in operating expenses	-436,194													-1,453,980
Change in fair value of derivative liabilities	8,216,218			-426,580										-400,433
Increase in interest expense related to derivative liabilities	-11,930													-622,937
Restatement Adjustment [Member]
Net gain or loss	$6,797,894			($1,785,795)										($10,810,086)
Net loss per share - basic and diluted (as restated) (in Dollars per share)	$0.05			($0.01)
Net loss per share - diluted (as restated) (in Dollars per share)	$0.03			($0.01)
Weighted average shares outstanding - basic (in Shares)	130,893,388			127,003,882
Weighted average shares outstanding diluted (in Shares)	204,722,215			127,003,882

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)		57,059,903
Cash, FDIC Insured Amount (in Dollars)	$250,000
Marketing and Advertising Expense (in Dollars)	$19,470	$4,535
Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments (Details)	3 Months Ended
	Mar. 31, 2013
Fair Value Disclosures [Abstract]
Fair Value Assumptions, Expected Dividend Rate	0.00%

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments (Details) - Financial liabilities measured at fair value on a recurring basis (USD $)	Mar. 31, 2013	Dec. 31, 2012
Fair Value of Financial Instruments (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities	$2,759,717	$10,964,005
Fair Value, Inputs, Level 1 [Member]
Fair Value of Financial Instruments (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Fair Value of Financial Instruments (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Fair Value of Financial Instruments (Details) - Financial liabilities measured at fair value on a recurring basis [Line Items]
Derivative liabilities	$2,759,717	$10,964,005

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments (Details) - Weighted average assumptions	3 Months Ended
	Mar. 31, 2013
Weighted average assumptions [Abstract]
Dividend Yield	0.00%
Volatility	85.43% - 85.99%
Risk-free Interest Rate	.11% - .77%
Term	1.7 - 4.0 years

Fair_Value_of_Financial_Instru5

Fair Value of Financial Instruments (Details) - Summary of the changes in the fair value of the Level 3 financial liabilities (USD $)	3 Months Ended
	Mar. 31, 2013
Summary of the changes in the fair value of the Level 3 financial liabilities [Abstract]
Balance - Beginning of period (as restated - see note 2)	$10,964,005
Balance - End of period	2,759,717
Aggregate fair value of derivative instruments issued	11,930
Change in fair value of derivative liabilities	($8,216,218)

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Property, Plant and Equipment [Abstract]
Depreciation	$1,264	$1,189

Property_and_Equipment_Details1

Property and Equipment (Details) - Property and equipment (USD $)	Mar. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Less: Accumulated depreciation	($8,417)	($7,153)
Net property and equipment	15,364	16,628
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Office Equipment	$23,781	$23,781

Intangibles_Details

Intangibles (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Disclosure Text Block [Abstract]
Interest Costs Capitalized	$0
Amortization of Intangible Assets	$66,965	$54,152

Intangibles_Details_Intangible

Intangibles (Details) - Intangible assets components (USD $)	Mar. 31, 2013	Dec. 31, 2012
Intangible assets components [Abstract]
Capitalized Software Development Costs	$1,334,745	$1,276,406
Less: Accumulated amortization	-419,923	-352,957
Net capitalized development costs	$914,822	$923,449

Intangibles_Details_The_capita

Intangibles (Details) - The capitalized development costs amortization (USD $)	Mar. 31, 2013
The capitalized development costs amortization [Abstract]
2013	$264,952
2014	262,063
2015	221,762
2016	126,813
2017	36,862
Thereafter	2,370
Total	$914,822

Income_Tax_Provision_Details

Income Tax Provision (Details) (USD $)	Mar. 31, 2013	Mar. 31, 2012
Income Tax Disclosure [Abstract]
Deferred Tax Assets, Operating Loss Carryforwards	$10,810,086	$14,318,115

Long_Term_Debt_Notes_Payable_D

Long Term Debt - Notes Payable (Details) (USD $)	3 Months Ended	43 Months Ended					3 Months Ended	12 Months Ended	3 Months Ended			12 Months Ended	0 Months Ended	1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Nov. 15, 2012	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2012
				Debenture [Member]	Debenture [Member]	Debenture [Member]	Exchange Agreement with Aztec [Member]	Exchange Agreement with Aztec [Member]	Securities Purchase Agreement [Member]	Securities Purchase Agreement [Member]	Securities Purchase Agreement [Member]	Securities Purchase Agreement [Member]	Purchase Agreement [Member]	Purchase Agreement [Member]	Purchase Agreement [Member]	Purchase Agreement [Member]
				Purchase Agreement [Member]
Long Term Debt - Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Effective Percentage							8.00%
Debt Conversion, Original Debt, Amount (in Dollars)	$0	$2,769,214					$545,958		$35,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)							3,733,428						12,500
Debt Instrument, Convertible, Conversion Price (in Dollars per share)							$0.15		$0.10
Share Price (in Dollars per share)							$0.40			$0.71		$0.71		$0.40		$0.40
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)							0.15		0.1	0.1		0.1	0.2
Debt Instrument, Unamortized Discount					200,535	213,500		341,224						225,000		225,000
Amortization of Financing Costs							244,205	96,519							29,632
Notes Payable, Related Parties, Noncurrent	905,484	905,484	236,500		390,484	236,500		301,253
Debt Instrument, Interest Rate, Stated Percentage									8.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)									6,500,000
Debt Instrument, Covenant Description									$465,000
Amortization of Other Deferred Charges										416,528	0	48,472				11,500
Debt Instrument, Unamortized Discount (Premium), Net	200,535	200,535		16,667					0	0		0
Long-term Debt, Gross										465,000		465,000
Proceeds from Issuance of Debt									50,000
Notes Payable, Noncurrent	399,465	399,465							515,000
Private Offering, Units Offered (in Shares)													3,000,000
Debt Instruments Purchase Price Per Unit													50,000
Debt Instrument, Face Amount													50,000
Number of Units Sold														450,000
Debt Instrument, Increase (Decrease), Net															$150,000

Warrant_Derivative_Liabilities1

Warrant Derivative Liabilities (Details) (USD $)	3 Months Ended		43 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
Warrant Derivative Liability [Abstract]
Derivative, Gain (Loss) on Derivative, Net	$8,216,218	($426,580)	($400,433)

Stockholders_Equity_Deficit_De

Stockholders' Equity (Deficit) (Details) (USD $)

3 Months Ended

2 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Apr. 30, 2012

Feb. 21, 2013

Mar. 31, 2013

Mar. 31, 2012

Mar. 31, 2013

Mar. 31, 2012

Dec. 31, 2012

Oct. 17, 2011

Sep. 01, 2011

Mar. 31, 2013

Jun. 13, 2012

Mar. 31, 2012

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Sep. 30, 2011

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Placement Agent Fees [Member]

Placement Agent Fees [Member]

Series A Preferred Stock [Member]

Long Term Incentive Plan [Member]

Warrant [Member]

Stockholders' Equity (Deficit) (Details) [Line Items]

Private Placement Authorized Amount (in Dollars)

$10,000,000

Private Placement Price Per Unit (in Dollars per share)

$1

Private Placement Number Of Share Component Per Unit

2

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

1

2,945,509

26,700

ConversionPricePerShare (in Dollars per share)

$0.07

$0.75

Private Placement Units Sold

445,000

Proceeds from Issuance of Private Placement (in Dollars)

-30,000

232,500

186,523

445,000

Private Placement Shares and Warrants Issued

890,000

Placement Agent Commission Percentage

10.00%

3.00%

Placement Agent Fees Cash (in Dollars)

44,500

Shares Offered in Escrow

25,000,000

Proceeds from Convertible Debt (in Dollars)

1,500,000

Debt Conversion, Converted Instrument, Shares Issued

1,500,000

22,091,311

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

0.1

Percentage Of Beneficial Ownership Interests

4.99%

Purchase Of Preferred Stock Shares

200,000

Capital Stock Shares Authorized

685,000,000

Common Stock, Shares Authorized

680,000,000

680,000,000

Preferred Stock, Shares Issued

1,700,000

1,700,000

5,000,000

Common Stock Shares Issued And Outstanding

125,135,112

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

35,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period

5,218,530

9,873,543

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

5,218,530

4,578,530

549,926

1,953,072

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)

$0.24

$0.24

Share-based Compensation (in Dollars)

41,506

763,480

436,194

0

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

0

13,285,842

Unamortized Share Based Compensation Expense (in Dollars)

3,940,039

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value (in Dollars)

$2

Stockholders_Equity_Deficit_De1

Stockholders' Equity (Deficit) (Details) - Assumptions used for employee stock options	3 Months Ended
	Mar. 31, 2013
Assumptions used for employee stock options [Abstract]
Risk-free interest rate	.77 to .86%
Dividend yield	0.00%
Stock price volatility	20% - 37%
Expected life	5 years 9 months

Stockholders_Equity_Deficit_De2

Stockholders' Equity (Deficit) (Details) - Stock Option Activity (USD $)	3 Months Ended
	Mar. 31, 2013
Stock Option Activity [Abstract]
Balance, December 31, 2012	9,460,543
Balance, December 31, 2012 (in Dollars per share)	$0.25
Balance, March 31, 2013	14,679,073
Balance, March 31, 2013 (in Dollars per share)	$0.25
Exercisable at 3/31/13	7,546,659
Exercisable at 3/31/13 (in Dollars per share)	$0.20
Non-vested at 3/31/13	7,132,414
Non-vested at 3/31/13 (in Dollars per share)	$0.30
Granted	5,218,530
Granted (in Dollars per share)	$0.24
Exercised	0
Exercised (in Dollars per share)	$0
Cancelled	0
Cancelled (in Dollars per share)	$0

Stockholders_Equity_Deficit_De3

Stockholders' Equity (Deficit) (Details) - Restricted Stock Activity	3 Months Ended
	Mar. 31, 2013
Restricted Shares Activity:
Restricted shares issued as of December 31, 2012	13,456,667
Granted during three months ended March 31, 2013	0
Forfeited during three months ended March 31, 2013	0
Total Restricted Shares Issued at March 31, 2013	13,456,667
Vested at March 31, 2013	-160,412
Unvested restricted shares as of March 31, 2013	13,296,255

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended	43 Months Ended	0 Months Ended	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2013	Nov. 09, 2012	Mar. 31, 2013
			Related Party [Member]	Related Party [Member]
Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Effective Percentage			8.00%
Debt Conversion, Original Debt, Amount (in Dollars)	$0	$2,769,214	$545,958
Debt Conversion, Converted Instrument, Expiration or Due Date				31-Mar-13
Conversion of Stock, Shares Issued (in Shares)				3,686,634
Debt Instrument, Convertible, Conversion Price (in Dollars per share)				$0.15

LiquidityGoing_Concern_Details

Liquidity-Going Concern (Details) (USD $)	3 Months Ended				0 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2013	6-May-13
					Subsequent Event [Member]
Liquidity-Going Concern (Details) [Line Items]
Proceeds from Issuance of Private Placement	($30,000)	$232,500	$186,523		$2,400,000
Retained Earnings (Accumulated Deficit)				$8,296,537

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Operating Leases, Rent Expense	$9,978	$0

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended	43 Months Ended	1 Months Ended
	Mar. 31, 2013	Mar. 31, 2013	6-May-13	6-May-13	Apr. 29, 2013
			Subsequent Event [Member]	Subsequent Event [Member]	Agreement With the LMD [Member]
			Convertible Debenture [Member]
Subsequent Events (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			10.00%		8.00%
Debt Conversion, Original Debt, Amount (in Dollars)	$0	$2,769,214	$2,400,000		$600,000
Securities Purchase Agreement, Shares Issued				1,200,000
Securities Purchase Agreement, Gross Proceeds (in Dollars)				$2,400,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)				$0.25
Debt Conversion, Converted Instrument, Shares Issued					20,000,000
Treasury Stock, Number of Shares Held					20,000,000